Abstract
INTRODUCTION
Lung transplantation can substantially improve survival and quality of life for patients suffering from end-stage pulmonary disease. Progress in transplantation surgery, intensive care medicine and immunosuppressive therapy has resulted in rapid growth of patients seeking lung transplantation [1] . As the demand for donor lungs definitely exceeds the number of transplanted lungs, patients still die while being on the waiting list. Various attempts such as initiation of the lung allocation score (LAS) [2] or introduction of ex vivo perfusion systems [3, 4] have led to decreased waiting time and increased organ availability.
Another way to increase the pool of potential lung donors is to expand the organ selection criteria. Due to the lack of organs that meet the traditional 'ideal lung donor criteria' proposed decades ago by various guidelines, many centres currently advocate a more liberal acceptance practice (reviewed in [5, 6] ). These extended donor criteria (EDC) include parameters such as potential smoking history, reduced oxygenation index [partial pressure of oxygen (PaO 2 )/fraction of inspired oxygen (FiO 2 )], size mismatch or prolonged ischaemic time. Although the use of EDC is not without controversy and clinical outcome parameters might be reduced compared with 'ideal' organs, this approach provides life-saving and quality of life-increasing therapy, especially for recipients who might otherwise remain on the waiting list.
Over the past few years, the age of lung donors in the context of EDC has gained increasing attention. Most guidelines still set the upper age limit for lung donors at 55 years, although in recent decades the median age of lung donors has steadily increased [1, 7] , as is also true for potential recipients on the †The first two authors contributed equally. waiting lists [8, 9] . Published data on clinical outcome of patients receiving older lungs are conflicting. Older studies, in particular, reported reduced survival rates, whereas a recent large singlecentre study demonstrated that lung transplantation from donors older than 55 years was associated with the worst short-and long-term outcomes [10] . Most studies published thus far consider donors aged 55 years and older as 'old'. We performed a retrospective analysis in a dual-centre study of the effect of donor age on outcome parameters after lung transplantation with a special focus on very old lung donors (aged 70-82 years).
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MATERIALS AND METHODS

Patients
Approval of this retrospective analysis of anonymized data was obtained by the Institutional Review Board (Ethikkomission Universit€ atsklinikum Giessen, approval number 207/14) as the longterm care of all patients after the transplantation was provided by the Pulmonary Department at the University Hospital of Giessen. Individual consent for patients included in this analysis was waived by the Institutional Review Board. Between January 2010 and June 2014, 96 patients with end-stage lung disease underwent lung transplantation in both centres. Eighty-six patients underwent surgery at the Department of Thoracic Surgery at the University Hospital of Giessen, and 10 patients were operated on at the Department of Thoracic Surgery at the Kerckhoff Clinic in Bad Nauheim.
In all patients, lung transplantation was performed using standardized techniques, and current protocols were followed for organ harvest and preservation. All donor lungs were examined by bronchoscopy, macroscopically inspected and assessed by the explant surgeon. Furthermore, oxygenation on 100% FiO 2 , duration of mechanical ventilation, smoking history, ischaemic time and medical history were considered for acceptance or rejection of the organ.
Acceptance policy of lungs originating from donors of very old age (!70 years)
The acceptance or rejection of each donor lung was discussed by our lung transplant team (transplant surgeon and pulmonologist). Recipient information included gender, age, diagnosis, type of transplant and need for extracorporeal membrane oxygenation (ECMO) therapy pretransplantation.
We initiated a restrictive acceptance policy for organs from very old donors. It consisted of accepting only lungs with a very short ventilation time (preferentially <4 days), a high PaO 2 /FiO 2 ratio (preferentially >400 mmHg), no infiltrates in the chest X-ray, no history of smoking or a history of very low exposure that had been stopped >10 years ago and a bronchoscopy without signs of infection.
During the allocation process, we tried not to transplant lungs derived from very old donors to very young patients. Without a pressing situation, we would not accept an age difference >30 years. However, given the reduced availability of donor organs and the urgent need for transplant in some patients, we went beyond this age difference if the requirement of a transplant procedure was deemed time critical.
Lungs were harvested by surgeons from the 2 transplant centres and flushed with ice-cold CelsiorV R solution including epoprostenol anterograde and retrograde via cannulas. After inflation, all lungs were transported on ice to the respective transplant centre. No ex vivo mechanical perfusion/ventilation system for the explanted lungs was used.
Initial and long-term immunosuppressive protocols were identical at both transplant centres. Protocols consisted of steroid induction with 2 Â 500 mg methylprednisolone, followed by 3 Â 125 mg methylprednisolone the first postoperative day. A triple-drug regimen consisting of tacrolimus (8-10 mg/l), mycophenolate mofetil (2 Â 1500 mg) and prednisolone was used. Prednisolone was tapered in all patients over the first year in an outpatient setting.
Data analysis
Data were analysed retrospectively. Donors were divided into 3 groups according to age (donors aged <60 years, donors aged 60-69 years and donors aged > _70 years).
For relevant outcome parameters, we chose survival, length of stay in hospital, mechanical ventilation post-transplant, best forced expiratory volume in 1 s (FEV 1 ), peak distance in 6-min walk test (6MWT) and dependency on dialysis posttransplantation.
We also assessed episodes of treated acute rejections. All transplanted patients underwent routine transbronchial biopsies 1, 3, 6, 9, 12, 24 and 36 months after transplantation or if the clinical suspicion of an acute rejection arose. Biopsies were graded according to the International Society for Heart and Lung Transplantation (ISHLT) 2006 statement [11] . Treatment of acute rejection was initiated for any grading A > _2, for B2R or for A1 + B1R. Treatment consisted of a 3-day pulse therapy of 500-1000 mg prednisolone per day, depending on the severity of the rejection.
Primary graft dysfunction (PGD) was assessed 72 h after transplant and graded according to the ISHLT Working Group on Primary Lung Graft Dysfunction definition [12] .
Statistics
Retrospective analysis of the study parameters was performed using SigmaStat 3.5 (Systat Software Inc., San Jose, CA, USA) and GraphPad Prism 7.0 (GraphPad Software Inc., La Jolla, CA, USA). Parameters are depicted as the mean ± standard deviation or percentage, as indicated. One-way analysis of variance with post hoc Student-Newman-Keul's test, one-way analysis of variance on ranks (Dunn's post hoc test) in case of not normally distributed variables or v 2 test in case of categorical variables were performed to analyse statistical differences. P-value <0.05 was accepted to indicate statistical significance.
RESULTS
Donor characteristics
Of the 96 lung transplant recipients included in the study, the majority (63 patients) received lungs from younger donors (Group 1: young donors; age <60 years, mean age 39.1 years; Table 1 ). Seventeen recipients received organs from donors aged 60-69 years (Group 2: old donors; mean age: 64.0 years), and 16 patients were transplanted with lungs from very old donors (Group 3: very old donors; age > _70 years, mean age: 74.2 years). Table 1 summarizes several donor-related characteristics subdivided into 3 age groups. Concerning the known smoking history of donors, the vast majority of donors in Group 3 were non-smokers (93.3%), whereas in the other cohorts, the percentage of donors with a negative smoking history was lower (Group 1: 65.5%; Group 2: 43.7%, P < 0.05). With regard to gender distribution among the 3 age-related groups of donors, the percentage of female donors was the lowest in the cohort of young donors. The time of mechanical ventilation before organ harvest differed significantly among the 3 groups with 4.9 ± 3.9 days for Group 1 (P < 0.05 versus both other groups), 3.1 ± 1.6 days in Group 2 and 2.5 ± 1.4 days in Group 3. We observed a slightly higher PaO 2 /FiO 2 index in the group of very old donors as compared to old and young donors, however, this failed to reach statistical significance.
Recipients
We observed no statistically significant age differences among the 3 particular age groups (Table 2) . Concerning the gender distribution among the recipients, the percentage of females was the lowest in the cohort of young donors and increased in old and very old donors. Interestingly, the underlying diagnosis of lung transplantation recipients varied only slightly between the different groups, however, the differences were not statistically significant.
With respect to the type of transplant, no single lung transplantation was performed with lungs from very old donors, whereas 9.5% and 5.9% of the recipients underwent single lung transplantation with organs from young and old donors, respectively.
The LAS as a parameter for the urgency status of the recipients did not differ significantly among the 3 age groups and ranged between 44 and 50. While the number of high LAS cases (LAS > _50) was lowest in the group of very old donors, this was not statistically significant. As well, the need for ECMO therapy before transplantation was similar among the different groups.
Outcome
In the next set of data, we analysed the effect of donor age on outcome parameters of lung transplant recipients (Table 3) . For early outcome variables, the need for mechanical ventilation post-transplant, length of stay in the hospital, use of perioperative ECMO, PGD and survival rates after 30 days and 3 months were investigated (Fig. 1) . No significant difference was observed for these parameters among the 3 donor age cohorts. The perioperative use of ECMO tended to be more pronounced in the group receiving lungs from very old donors, but this was not reflected in higher PGD 72 h after transplantation. Regarding mid-and long-term outcomes, recipients from young, old and very old organs showed similar 1-year (90-93%) and 3-year (73-87%) survival rates. Functional allograft quality was evaluated by post-transplant peak FEV 1 and the peak distance reached in 6MWT, which were performed during routine follow-up visits. We observed a significant difference in best FEV 1 in recipients of lungs from young donors (95.9 ± 21.0) compared with recipients who received lungs from old (90.0 ± 22.0) and very old donors (77.3 ± 11.2) (Fig. 2, P < 0.05) . Results of the 6MWT were comparable among the different groups and showed a good overall outcome (456 ± 73 m). The rate of treated acute rejection episodes was highest in the group of lungs from very old donors and was lowest in recipients with organs from young donors ( Table 3 , P < 0.05). Relevant bronchial complication in terms of airway stenosis, in most cases requiring interventional bronchoscopic procedures (e.g. balloon bronchoplasty and stent application), occurred in 13% of all recipients and did not differ among the different age groups. Similar results were observed for the incidence of dialysis therapy post-transplantation, which was comparable among the different donor age groups.
Notably, we detected 3 cases of non-tuberculous mycobacteria (NTM) in patients receiving lungs from very old donors that resulted in prolonged oral antibiotic therapy, whereas no NTM was found in lungs from younger donors (P < 0.05).
DISCUSSION
In this retrospective dual-centre study, we investigated the short-and long-term outcomes of patients receiving lung allografts from young donors (aged <60 years), old donors (aged 60-69 years) and very old donors (aged > _70 years). We demonstrate that lung transplantation using very old donors was not Table 3 . No statistically significant difference in survival was observed between groups. associated with worse survival rates compared with donors of younger age. In addition, peak 6MWT distance, rate of bronchial complications and dependency on dialysis therapy were comparable in all age groups. However, when analysing posttransplant lung function, we observed a significantly reduced best FEV 1 and an increased rate of treated acute rejections in recipients receiving allografts from very old donors. In summary, our data support the idea of expanding donor age limit and carefully considering even donors aged >70 years as potential candidates.
In order to create a balance between available donor lungs and patients listed for lung transplantation, an expansion of the donor pool is essential to reduce mortality and morbidity of patients on the waiting list. A suitable, yet debatable step is to extend the traditional 'ideal criteria' for donor selection [5, 6] . Compared to decades ago, a more liberal acceptance is now the standard of care in most transplant centres regarding donor smoking history, graft ischaemic time, size matching, oxygenation (PaO 2 /FiO 2 ratio) or abnormal radiographic findings. In this context, the discussion about pushing the acceptable age limit of a potential donor is an emerging field. Registry data indicate that acceptance of lungs from older donors is already a daily practice at many centres. In the year 2000, around 6% of all lung donors were aged 60 years and older, and in 2009, this number increased to 10.9% [13] . A report analysing registry data from the United Network for Organ Sharing (UNOS) and the ISHLT [14] demonstrated an association of very old donor age (>50 years [sic]), with increased post-transplant mortality originating from the mid-1990 s. However, a large multivariate analysis of outcome parameters from 21 Eurotransplant centres from the same time could not confirm the above-mentioned data [15] .
However, published data concerning survival and other outcome parameters for recipients of lung from older donors remain conflicting. Recently, large registry studies investigating transplant outcomes using older donor lungs were published. Brittle and colleagues retrospectively examined the impact of the donor age on post-transplant survival in 10 666 recipients registered in the UNOS database [13] . The authors demonstrated that outcomes of patients receiving lungs from donors aged 55-65 years were similar to those with the donors meeting the conventional age criteria (age <54 years). However, lung transplantation from donors aged 65 years and older was significantly associated with decreased intermediate-term survival. Probably, the largest cohort study was performed by Hayes et al., wherein they reviewed 23 905 lung transplants from the UNOS database performed between 1987 and 2013 retrospectively [16] . Results displayed no negative effect of lung transplants from old donors in older recipients in terms of survival; however, it did increase the risk of death in younger lung transplant recipients. In 2015, Sommer and colleagues published survival rates and outcomes after lung transplantation from donors aged 70 years and older [17] . They analysed a cohort of 27 donors aged >70 years and concluded that transplantation of these lungs is safe and does not compromise survival. In contrast, Baldwin et al. focused primarily on graft failure using data from the Organ Procurement and Transplantation Network and the Lung Transplant Outcomes Group analysing the outcome of 8860 lung transplant recipients [7] . They reported a highly significant difference in adjusted survival with the lowest survival rate found in the group receiving lungs from donors aged >65 years. However, they did not find a significant difference in PGD, which is consistent with our data. In our cohort, a higher use of perioperative ECMO was detected that failed to reach statistical significance, perhaps due to the small number of patients in our analysis. Pilcher et al. reported a lower PaO 2 /FiO 2 ratio in recipients receiving lungs from older donors, smokers and donors with low PaO 2 /FiO 2 ratios [18] . Our strict selection policy of accepting lungs with a high PaO 2 /FiO 2 from non-smokers might have contributed to the fact that we did not find a higher rate of PGD in the group of very old donors. Another aspect of the strict selection policy was the rejection of lungs from donors with a longer ventilation time, infiltrates and signs of infection. We limited allocation of lungs from very old donors to young recipients with an age difference of 30 years. We only deviated from this limit if the transplant seemed time critical due to the status of the recipient. Compared to the above-mentioned large cohort studies, clear limitations of our study include the much smaller cohort size and short follow-up time. Interestingly, we observed a higher rate of treated acute rejections in the group of very old donors. This finding is consistent with the results from a study that reported a higher hospitalization rate for acute rejections in patients receiving lungs from older donors in univariate and multivariate analyses [19] .
Nevertheless, we observed comparable survival rates even for recipients receiving lung allografts from very old donors. In addition to survival, outcome variables such as peak distance in 6MWT, renal or bronchial complications were comparable. The only parameter showing a significant difference was the posttransplant best FEV 1 value, which was decreased in recipients from very old lungs. This finding is consistent with previous epidemiological surveys depicting a significant decrease in lung function after the age of 60 years [20] . Aspects of normal lung ageing include dilatation of the alveoli and loss of supportive tissue and muscle tissue in the peripheral airways ('senile emphysema'), as well as comorbidities or life-long environmental factors (e.g. pollution). In terms of lung transplantation, Shigemura and colleagues reported reduced values in donors >55 years old [10] . Furthermore, Sommer et al. detected a decline in post-transplant FEV 1 after transplantation of lungs from donors aged >70 years compared to younger donors [17] . We were able to corroborate these findings in our study. However, in combination with a comparable 6MWT in recipients from all donor age groups, we found that during follow-up visits that recipients of very old lungs hardly described any limitations in everyday life due to this slightly reduced lung function. Furthermore, we incidentally detected NTM post-transplant in 3 of the 16 recipients receiving lungs from very old donors. This detection led to the induction of extended antimicrobial therapy. The rising incidence of NTM, which is often asymptomatic, is another characteristic of older lungs that should be considered during the individual post-transplant surveillance programme.
Another important factor that might be responsible for the comparable short-and long-term outcome data among the different age groups in our study is the restrictive acceptance policy concerning other EDC when considering an old/very old lung for transplantation. We attempted to accept only lungs with a very short ventilation time (preferentially <4 days), a high PaO 2 /FiO 2 ratio (preferentially >400 mmHg), no infiltrates in the chest X-ray, no history of smoking or a history of very low exposure that had been stopped >10 years ago and a bronchoscopy without signs of infection.
This policy is reflected by a better oxygenation index and significantly shorter ventilation time before harvest and significantly lower percentage of smokers compared to younger donors. In addition, our careful recipient selection was crucial for posttransplant outcomes. In our cohort, lung allograft from very old donors were only considered for bilateral lung transplantation and for patients who tended to have a lower urgency status compared to recipients from younger lungs.
Limitations
It is absolutely important to stress the limitations of the current study. We are presenting a retrospective data analysis, which inherently harbours a bias and is categorically incomparable to a randomized controlled trial. Furthermore, the total number of analysed patients is low and, therefore, the data should not be directly extrapolated to be true for other centres. In addition, we acknowledge that while selection of transplant candidates, acceptance of organs and peri-transplant procedures until hospital discharge were separately controlled by 2 different surgical teams, care for all transplanted patients in an outpatient setting was carried out in one centre. Again, we would like to further stress the notion that a bias in the selection of the lungs from very old donors was the restrictive selection policy in terms of smoking, ventilation time, high PaO 2 /FiO 2 , exclusion of infiltrates in the chest X-ray and missing signs of infection.
CONCLUSION
In conclusion, our dual-centre experience might encourage the careful consideration of lungs from very old donors for lung transplantation to provide life-saving and quality of lifeincreasing therapy to more patients with end-stage pulmonary disease on the transplant waiting list. In order to optimize posttransplant outcomes when transplanting very old lungs, stringent acceptance criteria for the other relevant parameters, careful recipient selection and rigorous surveillance strategies after transplantation are of major importance.
